Skip to content

Proteus OX19

by Cypress Diagnostics

Ref 5111

Proteus OX19 (5111) is an in vitro diagnostic device (EU IVDD general IVD; EMDN category rickettsia) made by Cypress Diagnostics, registered in EUDAMED on 26 Mar 2026 (Basic UDI-DI B-05404035102084), active as of 22 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05404035102084 Basic UDI-DI 05404035102084UDI-DIDate26 Mar 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / reference
5111
Primary DI / UDI-DI
05404035102084
Basic UDI-DI
B-05404035102084
EMDN code
W0105011705 Rickettsia
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Belgium

Manufacturer details

EUDAMED SRN
BE-MF-000000033

Similar devices in this category

Other devices filed under OTHER BACTERIOLOGY IMMUNOASSAYS.

Other devices from Cypress Diagnostics

See all devices from Cypress Diagnostics →

Properties

  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
Other properties (8, all answered No)